Award Result(NCB/EPSA6/RDF-R/PH/04/22)
March 20, 2023
Tender Code: (NCB/EPSA6/RDF-R/PH/04/22
Award Status: Partial Winners List
Award Date: 03/20/2023
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
|
Company Name: | Document No: OF/TM/ HO-16 | |||||||||
የኢትዮጵያ መድኃኒት አቅራቢ ኤጀንሲ | |||||||||||
Ethiopian Pharmaceuticals Supply Agency | |||||||||||
Title: | Effective date : 21/01/2022 | ||||||||||
Partial Official Winner List | Rev. No.: 1 | Page 1 of 1 | |||||||||
Tender no,: NCB/EPSA6/RDF-R/PH/04/22 | |||||||||||
Ser. No | Description | Unit | Allocated Quantity | Winner | Currency | Offered Unit price | Payement Term | Delivery site | Delivery Time | Remark | |
Supplier | EPSA warehouse AA | ||||||||||
42 | Sodium Chloride (Normal Saline) – 0.009 – Intravenous Infusion with Giving Set | 1000ml | 1,538,319 | Pharmacure PLC | ETB | 110.00 | COD | EPSA Warehouse AA | As per EPSA’s Schedule | Winner | |
1000ml | 500,004 | Addis Parmaceutical Factory (APF) Sc. | ETB | 130.15 | COD | EPSA Warehouse AA | As per Bidding Document | 2nd Least price (Will be awarded only if agreed to supply with the winner’s price) | |||
እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Official winner list OF/TM/HO-16, 1, 21/01/2022 | ||||||||||
Make sure that this is the correct issue before use | |||||||||||
Reason for Rejection
|
Company Name: | Document No: OF/TM/ HO-17 | |||||
የኢትዮጵያ መድኃኒት አቅራቢ ኤጀንሲ | |||||||
Ethiopian Pharmaceuticals Supply Agency | |||||||
Title: | Effective date : | 21/01/2022 | |||||
Reason for Rejection | Rev. No.: 1 | Page 1 of 1 | |||||
Tender no,:NCB/EPSA6/RDF-R/PH/04/22 | |||||||
Item No | Product Description | Name of competitor suppliers | Status | Reason of unsuccessfulness(if it is unsuccessful) | Remark | ||
42 | Sodium Chloride (Normal Saline) – 0.009 – Intravenous Infusion with Giving Set | Pharmacure PLC | Winner | **************** | |||
Addis Parmaceutical Factory (APF) Sc. | ………………. | Price incompetency | |||||
እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Reasons for Rejection, OF/TM/HO-17, 1, 21/01/2022 | ||||||
Make sure that this is the correct issue before use | |||||||